Victrex’s (VCT) “Buy” Rating Reaffirmed at Liberum Capital

Liberum Capital reissued their buy rating on shares of Victrex (LON:VCT) in a research note issued to investors on Tuesday. The firm currently has a GBX 2,440 ($32.84) price target on the stock.

VCT has been the topic of a number of other research reports. Barclays dropped their price objective on Victrex from GBX 2,350 ($31.63) to GBX 2,270 ($30.55) and set an equal weight rating on the stock in a report on Tuesday, November 28th. Berenberg Bank upgraded Victrex to a buy rating and increased their price objective for the stock from GBX 2,000 ($26.92) to GBX 2,600 ($34.99) in a report on Wednesday, September 6th. Peel Hunt increased their price objective on Victrex from GBX 2,100 ($28.26) to GBX 2,300 ($30.96) and gave the stock an add rating in a report on Tuesday, September 5th. Deutsche Bank reaffirmed a hold rating on shares of Victrex in a research report on Thursday, August 24th. Finally, J P Morgan Chase & Co reaffirmed a neutral rating and set a GBX 2,150 ($28.94) target price on shares of Victrex in a research report on Wednesday, September 27th. Eight investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Victrex currently has an average rating of Hold and an average target price of GBX 2,248.91 ($30.27).

Shares of Victrex (LON:VCT) traded up GBX 122 ($1.64) on Tuesday, hitting GBX 2,513 ($33.82). The stock had a trading volume of 264,300 shares, compared to its average volume of 238,635. Victrex has a one year low of GBX 1,695 ($22.81) and a one year high of GBX 2,607 ($35.09).

WARNING: “Victrex’s (VCT) “Buy” Rating Reaffirmed at Liberum Capital” was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://ledgergazette.com/2017/12/06/victrexs-vct-buy-rating-reaffirmed-at-liberum-capital.html.

About Victrex

Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets.

Analyst Recommendations for Victrex (LON:VCT)

Receive News & Ratings for Victrex plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex plc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply